Identification of a Biomarker Predictive of Evolution of Parkinson Disease
Status:
Recruiting
Trial end date:
2024-10-16
Target enrollment:
Participant gender:
Summary
Phase II, Open-labeled, Prospective, Multi-center study of assessing the link between
microglial activation and dopaminergic denervation kinetics in the early stage of Parkinson
disease, by using the imaging of [18F]DPA-714 a new ligand of Translocator Protein-18 kDa
(TSPO) by Positron Emission Tomography (PET).